Fresenius Medical Care
€39.55Change from previous close: −0.33%Absolute change: −€0.13
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- €10.6B
- Enterprise value
- €21.45B
- P/E (trailing 12 months)
- 11.9
- Forward P/E
- 9.28
- PEG
- 0.73
- Price/book
- 0.84
- Price/sales
- 0.55
- EV/EBITDA
- 7.88
- EV/revenue
- 1.10
Profitability and growth
- Gross margin
- 26.4%
- Operating margin
- 10.8%
- Net margin
- 4.8%
- ROE
- 8.5%
- ROA
- 4.0%
- ROIC
- 6.6%
- Revenue growth (year over year)
- 1.4%
- Earnings growth (year over year)
- 5.5%
Financial health
- Total cash
- €1.06B
- Total debt
- €10.98B
- Debt/equity
- 0.81
- Current ratio
- 1.07
- Quick ratio
- 0.63
- Altman Z-Score
- 1.78
- Piotroski F-Score
- 7.00
Dividends
- Annual dividend per share
- €1.49
- Dividend yield
- 3.8%
- Payout ratio
- 44.9%
- Ex-dividend date
- May 22, 2026
Analysts and estimates
- Average price target
- €41.69
- Median price target
- €41.00
- High price target
- €67.00
- Low price target
- €30.00
- Analysts with a price target
- 17
- Consensus
- Hold
- Forward EPS
- €4.25
- EPS estimate, current year
- €4.06
Shares and trading
- Beta
- 0.83
- Average volume
- 774.49K
- Shares outstanding
- 268.56M
- Float
- 198.56M
- Institutional ownership
- 52.6%
- Insider ownership
- 25.0%